MIMs is proud to join the team led by Dr. Celia Greenwood (Lady Davis Institute for Medical Research) and Dr. Karim Oualkacha (UQÀM) to accelerate the development of a precision medicine in order to develop a series of software tools capable to analyze DNA methylation.

These tools will allow academic scientific and industries to better integrate cellular epigenomic dimension in the basis of pathology research including cancer, brain disorders, neurodegenerative disorders and mental illnesses.